Probiotics and Overreaching Recovery
Probiotics for Athlete's Recovery and Immune System
1 other identifier
interventional
16
0 countries
N/A
Brief Summary
Overloading is a key training principle used by athletes and coaches to improve physical performance. Intensified training periods are therefore commonly incorporated into the course of a regular training season. From a clinical point of view, very intense periods of training are associated with a temporary immunological deficiency which can lead to teh "overreaching syndroms". During periods of overreaching, nutritional strategies are mainly aimed at ensuring sufficient amounts of energy to support the increase in effort. However less is known about nutritional supplements to attenuated the inflammatory/immunological response to training stress. Probiotic bacteria are defined as live food ingredients beneficial to the host's health. Numerous health benefits have been attributed to probiotics, including effects on gastrointestinal tract function and disease, immune function, hyperlipidemia, hypertension, and allergic conditions. Studies in the literature on the ergogenic effect of probiotics in athletes are still scarce today. this study aims to explore the potential role of probiotics on performance, recovery from fatigue and immune function during intensive period of training.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2021
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 7, 2021
CompletedFirst Posted
Study publicly available on registry
May 13, 2021
CompletedStudy Start
First participant enrolled
June 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedMay 13, 2021
May 1, 2021
4 months
May 7, 2021
May 7, 2021
Conditions
Outcome Measures
Primary Outcomes (3)
lymphocyte subpopulation total T (CD3+)
lymphocyte subpopulation: total T (CD3+) %
Change from baseline to up to 15 days
T-helper (CD4+)
lymphocyte subpopulation: T-helper (CD4+) %
Change from baseline to up to 15 days
T-suppressor (CD8+)
lymphocyte subpopulation: T-suppressor (CD8+) %
Change from baseline to up to 15 days
Study Arms (2)
Probiotics
EXPERIMENTALparticipants will train for 15 days while consuming the dietary supplement. During the last 8 days the intensity of training will increase to induce overreaching.
Placebo
PLACEBO COMPARATORparticipants will train for 15 days while consuming the dietary supplement. During the last 8 days the intensity of training will increase to induce overreaching.
Interventions
Eligibility Criteria
You may qualify if:
- age 25-55 years
- Body mass index:\> 18 and \<30 kg / m2
- Stable body weight for at least 3 months
- regular practice of physical activity for at least 2 years
You may not qualify if:
- Chronic diseases (cardiovascular, hepatic, respiratory, cancer)
- Acute inflammatory states, infections or other pathologies
- Regular use of probiotics
- Use or treatment with steroids (within the previous 3 months)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 7, 2021
First Posted
May 13, 2021
Study Start
June 1, 2021
Primary Completion
September 30, 2021
Study Completion
December 31, 2021
Last Updated
May 13, 2021
Record last verified: 2021-05
Data Sharing
- IPD Sharing
- Will not share